Abstract
SPAN-PD: Subgroup Analyses by Baseline Characteristics of Patients Treated With Levodopa Inhalation Powder 84mg or Placebo to Treat OFF Symptoms in Patients With Parkinson’s Disease (PD) as Measured by Unified Parkinson’s Disease Rating Scale Part III (UPDRS-III) Score and Patient Global Impression of Change (PGIC) (P10-11.005)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
